ClinicalTrials.gov
public full text
Public Domain
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one of the GIVINOSTAT studies.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Givinostat for treating Duchenne muscular dystrophy in people 6 years and over#348232
- Duchenne muscular dystrophy disease severity impacts skeletal muscle progenitor cells systemic delivery#492037
- Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy#1137260
- Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients#800937
- 42 U.S.C. § 284j — Muscular dystrophy research#595172
Record · ID 908687
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive